Merck and Daichii Sankyo withdraw US approval request for lung cancer drug
-- Pharmaceutical companies, Daichii Sankyo and Merck (NSE:PROR), on Thursday made the decision to pull back their...
-- Pharmaceutical companies, Daichii Sankyo and Merck (NSE:PROR), on Thursday made the decision to pull back their...
-- Fast-fashion retailer Shein announced on Thursday that it plans to significantly increase its product safety and...
-- JetBlue Airways (NASDAQ:JBLU) and United Airlines announced on Thursday a consumer collaboration plan, "Blue...
-- Keros Therapeutics announced on Thursday the discontinuation of all development of its drug, cibotercept, for...
By David Shepardson (Reuters) -JetBlue Airways and United Airlines unveiled on Thursday plans for a consumer collaboration that...
-- Nvidia (NASDAQ:NVDA) is facing new accusations from U.S. lawmakers over its close ties with China, according to a...
MILAN (Reuters) -Stellantis’ newly appointed CEO Antonio Filosa on Thursday picked Europe to kick off a tour of the automaker’s...
-- The S&P 500 rallied on the back of a U.S. court decision striking down key tariff measures, but Barclays warns...
-- Shell (LON:SHEL) on Thursday announced plans to acquire TotalEnergies (LON:TTEF)’ stake in an offshore Nigerian...
By Sam Nussey TOKYO (Reuters) -Sony’s CEO said on Thursday the spin-off of the financial services arm will secure that business...